期刊文献+

同种异体骨制备保存研究进展 被引量:4

暂未订购
导出
摘要 同种异体骨已成为临床上治疗创伤、肿瘤、感染、骨吸收等原因所致骨缺损移植的重要材料。同种异体骨的制备保存一直是骨移植研究的重点。目前主要有低温、深冻或冻干等保存方法,再经灭菌和消除免疫原性等处理.制备出清洁、无菌、无病毒、保留一定生物活性和生物力学特性的同种异体骨。该文就同种异体骨制备保存的研究进展作一综述。
出处 《国际骨科学杂志》 2008年第5期320-321,339,共3页 International Journal of Orthopaedics
基金 浙江省科技厅基金(2007C33026) 浙江省新苗计划(2007R40-G2010003)
  • 相关文献

参考文献26

  • 1Khan SN, Cammisa FP, Sandhu HS. et al. The biology, of bonegrafting. J .Am Acad Orthop Surg, 2005. 13(1):77-86.
  • 2Tomford WW. Bone allografts: past, present and future. Cell Tissue Bank, 2000. 1(2),105-109.
  • 3Williams JM. Virdi AS, Pylawka TK, et al. Prolonged-fresh preservation of intact whole canine femoral condyles for the potential use as osteochondral allografts. J Orthop Res, 2005.23(4):831- 837.
  • 4Bugbee WD. Fresh osteochondral allografts J Knee Surg, 2002.15(3);191-195.
  • 5Wingenfeld C, F.gli RJ, Hernpfing A, et al. Cryopreservation of osteochondral allografts: dimethyl sulfoxide promotes angiogenesis and immune tolerance in nice: J Bone Joint Surg Am, 2002; 84(8):1420-1429.
  • 6Nather A, Thambyah A. Goh JC. Biomechanical strength of deep-frozen versus lyophilized large cortical allografts. Clin Piomech (Bristol, Avon), 2004; 19(5), 526-533.
  • 7Zipfel GJ, Guiot BH, Fessler RG. Bone grafting Neurosurg Fccus, 2003; 14(2) :e8.
  • 8Sirnpson D, Kakarala G, Hampson K, et al. Viable cells survive in fresh frozen human bone allografts. Acta Orthop, 2007. 78(1):26-30.
  • 9Egili RJ,Sckell A,Fraitzl CR,et al.Cryopresservation with dimethyl sulfoxide sustains partially the biological function of osteochondral tissue Bone.2003.33(3):352-361.
  • 10陈庆,顾洁夫,蔡林.重组复合异体冻干骨修复节段性骨缺损的实验研究[J].中国修复重建外科杂志,2003,17(1):5-8. 被引量:16

二级参考文献13

  • 1毕树雄,戴尅戎,汤亭亭.IL-4与IL-10联合诱导异种骨移植免疫耐受的体外研究[J].实用骨科杂志,2004,10(4):334-336. 被引量:1
  • 2Platt JL. New directions for organ transplantation [J]. Nature, 1998,392:11-17.
  • 3Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine networks in transplantation [J]. Transplantation, 1997,63:489 -494.
  • 4He XY,Chen J,Verma N,et al. Treatment with interleukin-4 prolongs allogeneic neontal heart graft survival by inducing T helper 2 responses [J]. Transplantation, 1998,65:1145-1152.
  • 5Li W, Fu F, Lu L, et al. Differential effects of exogenous interleukin10 on cardiac allograft survival:inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function[J]. Transplantation, 1999,68:1402-1409.
  • 6Morris SC, Gause WC, Finke lman FD. IL-4 suppression of in vivo T cell activation and antibody production [J]. J Immunol, 2000, 164:1734-1740.
  • 7Rabinovitch A, Suarez-Pinzon WL, sorensen O, et al. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice:analysis of cytokine mRNA expression in the graft[J]. Transplantation,1995,60:368-374.
  • 8Feng X,Zheng XX,Yi S,et al. IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival [J]. Transplantation,1999,68:1775-1783.
  • 9Simeonovic CJ,Townsend MJ,Morris CF,et al. Immune mechanisms associated with rejection of fetal murine proislet allografts and pig proislet xenografts:comparison of intragrafi cytokine mRNA profiles [J]. Transplantation, 1999,67:963-971.
  • 10Stevenson S. Biology of bone grafts [J]. Orthop Clin Nor Am, 1999,30:543-552.

共引文献20

同被引文献70

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部